Xilazina 10%

XYLAZINA 10%; Description; : Xylazine-based sedative, muscle relaxant, and analgesic for horses; Composition; : Xylazine (as hydrochloride): 100 mg; Excipients q.s.: 1 ml; Action; : Sedative, muscle relaxant, and analgesic; Indications; : Xylazine 10% is indicated for the following cases:; Diagnostic procedures: ophthalmic or oral examination, abdominal or rectal palpation, vaginal examination, placement of a urinary or nasogastric tube, X-rays; Clinical procedures: dewclaw removal, shoeing, etc; Minor surgeries requiring only sedation and mild analgesia, wound care, suturing in combination with local anesthesia, etc; Management of uncooperative animals; As a preanesthetic or as an adjunct to local surgeries; Warnings; : Due to its depressant effect on the central nervous system, extreme caution must be exercised when using this product in animals with severe respiratory depression, heart failure, or deep shock. It should not be administered via the intracarotid route. When using the intravenous route, exercise extreme caution when administering via the jugular vein; Side; Effects: At the recommended doses, mild muscle tremors, bradycardia with partial atrioventricular block, and decreased respiratory rate may be observed. All of these side effects resolve spontaneously once the sedative effect wears off; The recommended dose does not cause any intoxication or overdose; PACKAGING; : 20- and 50-ml vials; DOSAGE; Sedation:; Intravenous: 0.5 ml/50 kg of body weight (1 to 1.1 mg/kg). Intramuscular: 1 ml/50 kg of body weight (2 to 2.2 mg/kg); After administering 10% Xylazina, the horse should be kept in a quiet environment until the maximum sedative effect is achieved; Administration of the indicated dose produces sedation for a period of 1 to 2 hours, with analgesia during the first 15 to 30 minutes; Adjuvant to local anesthesia:; It is used at the same doses indicated for sedation in conjunction with locally administered lidocaine; Preanesthetic:; It is used at the same doses as for sedation. Due to the additive effect of central nervous system depression, only 1/2 to 1/3 of the barbiturate dose should be administered to achieve a level of surgical anesthesia; Interval between doses:; If necessary, the dose may be repeated in full or in part at the veterinarian’s discretion; The recommended repeat dose is: 0.25 mL/50 kg (0.5 mg/kg) administered intravenously; APPLICATION; : Injectable